India  

'Bharat Biotech's Covaxin shows 77.8% efficacy in phase 3 trials'

IndiaTimes Tuesday, 22 June 2021
Bharat Biotech's Covaxin has demonstrated 77.8% efficacy in phase 3 trials, reported ANI quoting sources. The Hyderabad-based firm had earlier submitted the trial data to the Subject Expert Committee of the Indian drug regulator. The panel has approved the trial data which is based on 25,800 subjects. Covaxin is one of the three Covid vaccines currently in use in India.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Bharat Biotech's Covaxin 77.8 per cent effective in protecting against COVID-19| Oneindia News

Bharat Biotech's Covaxin 77.8 per cent effective in protecting against COVID-19| Oneindia News 02:03

Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against COVID-19 according to data from Phase III trials conducted on 25,800 participants across India. The data was submitted to the DCGI over the weekend. #BharatBiotech #Covaxin #Covid19

You Might Like


💡 newsR Knowledge: Other News Mentions

Covaxin Covaxin Vaccine against COVID-19

CDC lifts US travel hurdles for Covaxin trial participants by putting it on qualifying vaccine list under exceptions

At a time when the World Health Organisation (WHO) is dithering on granting Emergency Use Listing (EUL) to Bharat Biotech’s Covaxin, the United States Centres..
IndiaTimes
Covaxin’s EUL nod halted, WHO sought additional clarification | Oneindia News [Video]

Covaxin’s EUL nod halted, WHO sought additional clarification | Oneindia News

Covaxin’s emergency use is still on hold as WHO sought additional clarification from the vaccine’s manufacturer Bharat Biotech. The technical advisory group will now meet on November 3 for a final assessment. #Covaxin #BharatBiotech #WorldHealthOrganisation

Credit: Oneindia    Duration: 02:24Published

Covaxin yet to get EUL, WHO seeks 'additional clarifications' from Bharat Biotech

The Covaxin jab has been approved in 14 countries and 70 million doses have been distributed overseas, Bharat Biotech told World Health Organisation.
DNA
No bail for Aryan Khan today, arguments to continue in Bombay High Court tomorrow | Oneindia News [Video]

No bail for Aryan Khan today, arguments to continue in Bombay High Court tomorrow | Oneindia News

The Bombay High Court will resume hearing Aryan Khan's bail plea at 2.30 pm tomorrow; A WHO technical advisory group reviewed data on Covaxin; Congress general secretary Priyanka Gandhi Vadra suggestion to party leaders; According to a study led by the University of Oxford in the UK, Covid-19 is more likely to cause very rare neurological conditions than vaccination with the AstraZeneca or Pfizer preventives. #BombayHC #AryanKhan #NCB

Credit: Oneindia    Duration: 02:18Published

Bharat Biotech Bharat Biotech Indian multinational biotechnology company and vaccine manufacturer

Review of Covaxin by WHO underway; expect a recommendation within 24 hours: Spokesperson

Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine's Emergency Use..
IndiaTimes

We are waiting for DCGI approval for children's Covid-19 vaccine: Bharat Bitoech Chairman

Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India..
IndiaTimes

Hyderabad Hyderabad Capital of Telangana, India

Telangana: Heavy rainfall lashes parts of Hyderabad causing heavy waterlogging | Oneindia News [Video]

Telangana: Heavy rainfall lashes parts of Hyderabad causing heavy waterlogging | Oneindia News

Yesterday, heavy rainfall lashed many parts of Hyderabad city. Roads and the low-lying areas are inundated with water after the downpour. Nalas in Vanasthalipuram and Kukatpally have overflowed due to heavy rains. #Telangana #Rainfall #Hyderabad

Credit: Oneindia    Duration: 01:48Published
Cyclone Gulab: Hyderabad on high alert as IMD warns of heavy rain | Oneindia News [Video]

Cyclone Gulab: Hyderabad on high alert as IMD warns of heavy rain | Oneindia News

The city of Hyderabad is put on high alert after the IMD issued warning of very heavy rainfall. While rainfall started on September 27, due to Cyclone Gulab, the impact might last up to September 29 the IMD had said. #CycloneGulab #Covid19Research #BharatBandh

Credit: Oneindia    Duration: 04:06Published
Asaduddin Owaisi’s residence in Delhi vandalised by Hindu Sena members | Oneindia News [Video]

Asaduddin Owaisi’s residence in Delhi vandalised by Hindu Sena members | Oneindia News

Hyderabad MP Asaduddin Owaisi’s official residence in Delhi was vandalised by members of Hindu Sena. Delhi police said that they have arrested five men. The incident took place on Tuesday evening, #SAACMeetingcalledoff #Pakistan #Taliban

Credit: Oneindia    Duration: 02:02Published
Hyderabad becomes part of Union of India | September 17 in History | Oneindia News [Video]

Hyderabad becomes part of Union of India | September 17 in History | Oneindia News

Hyderabad became a part of the union of India on this day in 1948, thirteen months after the independence of the country. The military was called in to crush a militia resistance forcing the king of Hyderabad to surrender. #HyderabadDay #militia #unionofindia

Credit: Oneindia    Duration: 02:46Published

COVID-19 COVID-19 Contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Kerala Minister says over 41 pregnant women died of Covid, 149 affected ended lives | Oneindia News [Video]

Kerala Minister says over 41 pregnant women died of Covid, 149 affected ended lives | Oneindia News

Today, Kerala’s Health Minister Veena George said that 41 pregnant women have so far died due to Covid-19 in Kerala and also stated that the number of the Covid positive persons, who had killed themselves in the state stood at 149, so far. #Kerala #Covid19 #CovidDeaths

Credit: Oneindia    Duration: 01:48Published

Labour leader Keir Starmer tests positive for COVID

Labour leader Sir Keir Starmer has tested positive for coronavirus.
Sky News

Sunak outlines plans for 'new economy' after COVID - but issues warnings

Chancellor Rishi Sunak has set out new government spending rules as he outlined a budget to prepare for a "new economy" after the COVID crisis.
Sky News
Karnataka reports two cases of new Covid-19 variant | Oneindia News [Video]

Karnataka reports two cases of new Covid-19 variant | Oneindia News

Karnataka has reported two cases of the new Covid-19 variant known as AY.4.2 in the state. The information was shared by Karnataka Health Minister Dr K Sudhakar on Tuesday. #KarnatakaCovid-19update #JoeBidenonIsrael #Pakistanecomony

Credit: Oneindia    Duration: 02:24Published

Brazil senators recommend president face crimes against humanity charges over COVID policies

Brazil's President Jair Bolsonaro should face a series of criminal indictments over his response to the coronavirus pandemic, according to a committee of the..
Sky News

Related videos from verified sources

Covaxin neutralizes both Alpha & Delta variants of coronavirus: US Institute| Oneindia News [Video]

Covaxin neutralizes both Alpha & Delta variants of coronavirus: US Institute| Oneindia News

Studies carried out by the top American health research institute finds that Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), effectively..

Credit: Oneindia     Duration: 02:11Published
Zydus Cadila caps clinical trials of DNA vaccine for minors | Vaccines for children | Oneindia News [Video]

Zydus Cadila caps clinical trials of DNA vaccine for minors | Vaccines for children | Oneindia News

Yesterday, the Centre informed the Supreme Court that Zydus Cadila, which is developing a DNA vaccine, has completed its clinical trials for the 12 to 18 age group. The government added that the Drugs..

Credit: Oneindia     Duration: 01:29Published
Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News [Video]

Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News

Bharat Biotech has submitted Phase 3 clinical trial data for its Covid-19 vaccine, Covaxin, to the Drug Controller General of India (DCGI). The development comes nearly five months after Covaxin was..

Credit: Oneindia     Duration: 02:02Published

Related news from verified sources

Covid: Karnataka to ease lockdown restrictions in graded manner

​​Weekend curfew would be in force from 7pm on June 18 to 5am on June 21. Night curfew would be in force on each night on remaining days between 7pm to 5am...
IndiaTimes

'Bharat Biotech's Covaxin shows 77.8% efficacy in phase 3 trials'

Bharat Biotech's Covaxin has demonstrated 77.8% efficacy in phase 3 trials, reported ANI quoting sources. The Hyderabad-based firm had earlier submitted the...
IndiaTimes